Figure 1From: Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia Breast Cancer Patient with Metastatic Disease to Flat Bones with Two Prior Chemotherapy Regimens--Current Regimen is Doxorubicin.Back to article page